vs
HOVNANIAN ENTERPRISES INC（HOV）与通用电气医疗（OPCH）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是HOVNANIAN ENTERPRISES INC的1.8倍（$1.4B vs $817.9M），通用电气医疗净利率更高（3.6% vs -0.1%，领先3.7%），通用电气医疗同比增速更快（12.2% vs -16.5%），HOVNANIAN ENTERPRISES INC自由现金流更多（$164.0M vs $130.2M），过去两年HOVNANIAN ENTERPRISES INC的营收复合增速更高（17.3% vs 13.0%）
霍夫纳尼安企业是美国知名房地产企业，业务覆盖住宅开发全流程，包含设计、建造与销售，产品线丰富，不仅开发独立独栋住宅，也开发联排别墅、公寓以及养老住宅等高密度居住物业。
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、磁共振、女性健康筛查及X线设备）、超声、患者护理解决方案（覆盖远程患者监测、麻醉呼吸护理、心脏病诊断、婴儿护理等）及制药相关业务。
HOV vs OPCH — 直观对比
营收规模更大
OPCH
是对方的1.8倍
$817.9M
营收增速更快
OPCH
高出28.7%
-16.5%
净利率更高
OPCH
高出3.7%
-0.1%
自由现金流更多
HOV
多$33.7M
$130.2M
两年增速更快
HOV
近两年复合增速
13.0%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $817.9M | $1.4B |
| 净利润 | $-667.0K | $51.8M |
| 毛利率 | — | 19.0% |
| 营业利润率 | -0.5% | 5.9% |
| 净利率 | -0.1% | 3.6% |
| 营收同比 | -16.5% | 12.2% |
| 净利润同比 | -100.7% | -3.8% |
| 每股收益（稀释后） | $-0.57 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HOVOPCH
| Q4 25 | $817.9M | — | ||
| Q3 25 | $800.6M | $1.4B | ||
| Q2 25 | $686.5M | $1.4B | ||
| Q1 25 | $673.6M | $1.3B | ||
| Q4 24 | $979.6M | $1.3B | ||
| Q3 24 | $722.7M | $1.3B | ||
| Q2 24 | $708.4M | $1.2B | ||
| Q1 24 | $594.2M | $1.1B |
净利润HOVOPCH
| Q4 25 | $-667.0K | — | ||
| Q3 25 | $16.6M | $51.8M | ||
| Q2 25 | $19.7M | $50.5M | ||
| Q1 25 | $28.2M | $46.7M | ||
| Q4 24 | $94.3M | $60.1M | ||
| Q3 24 | $72.9M | $53.9M | ||
| Q2 24 | $50.8M | $53.0M | ||
| Q1 24 | $23.9M | $44.8M |
毛利率HOVOPCH
| Q4 25 | — | — | ||
| Q3 25 | — | 19.0% | ||
| Q2 25 | — | 19.0% | ||
| Q1 25 | — | 19.7% | ||
| Q4 24 | — | 21.3% | ||
| Q3 24 | — | 20.1% | ||
| Q2 24 | — | 20.3% | ||
| Q1 24 | — | 20.8% |
营业利润率HOVOPCH
| Q4 25 | -0.5% | — | ||
| Q3 25 | 3.0% | 5.9% | ||
| Q2 25 | 3.9% | 5.8% | ||
| Q1 25 | 5.9% | 5.9% | ||
| Q4 24 | 12.0% | 6.9% | ||
| Q3 24 | 13.5% | 6.7% | ||
| Q2 24 | 9.8% | 6.6% | ||
| Q1 24 | 5.5% | 6.0% |
净利率HOVOPCH
| Q4 25 | -0.1% | — | ||
| Q3 25 | 2.1% | 3.6% | ||
| Q2 25 | 2.9% | 3.6% | ||
| Q1 25 | 4.2% | 3.5% | ||
| Q4 24 | 9.6% | 4.8% | ||
| Q3 24 | 10.1% | 4.2% | ||
| Q2 24 | 7.2% | 4.3% | ||
| Q1 24 | 4.0% | 3.9% |
每股收益（稀释后）HOVOPCH
| Q4 25 | $-0.57 | — | ||
| Q3 25 | $1.99 | $0.32 | ||
| Q2 25 | $2.43 | $0.31 | ||
| Q1 25 | $3.58 | $0.28 | ||
| Q4 24 | $12.47 | $0.36 | ||
| Q3 24 | $9.75 | $0.31 | ||
| Q2 24 | $6.66 | $0.30 | ||
| Q1 24 | $2.91 | $0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $309.8M |
| 总债务越低越好 | $900.7M | $1.2B |
| 股东权益账面价值 | $830.9M | $1.4B |
| 总资产 | $2.6B | $3.5B |
| 负债/权益比越低杠杆越低 | 1.08× | 0.86× |
8季度趋势，按日历期对齐
现金及短期投资HOVOPCH
| Q4 25 | — | — | ||
| Q3 25 | — | $309.8M | ||
| Q2 25 | — | $198.8M | ||
| Q1 25 | — | $171.4M | ||
| Q4 24 | — | $412.6M | ||
| Q3 24 | — | $483.0M | ||
| Q2 24 | — | $376.9M | ||
| Q1 24 | — | $219.5M |
总债务HOVOPCH
| Q4 25 | $900.7M | — | ||
| Q3 25 | $861.9M | $1.2B | ||
| Q2 25 | $864.3M | $1.1B | ||
| Q1 25 | $893.7M | $1.1B | ||
| Q4 24 | $896.2M | $1.1B | ||
| Q3 24 | $898.7M | $1.1B | ||
| Q2 24 | $933.0M | $1.1B | ||
| Q1 24 | $934.6M | $1.1B |
股东权益HOVOPCH
| Q4 25 | $830.9M | — | ||
| Q3 25 | $835.4M | $1.4B | ||
| Q2 25 | $820.4M | $1.4B | ||
| Q1 25 | $811.4M | $1.4B | ||
| Q4 24 | $800.3M | $1.4B | ||
| Q3 24 | $703.4M | $1.4B | ||
| Q2 24 | $647.0M | $1.4B | ||
| Q1 24 | $607.1M | $1.4B |
总资产HOVOPCH
| Q4 25 | $2.6B | — | ||
| Q3 25 | $2.6B | $3.5B | ||
| Q2 25 | $2.6B | $3.4B | ||
| Q1 25 | $2.5B | $3.3B | ||
| Q4 24 | $2.6B | $3.4B | ||
| Q3 24 | $2.5B | $3.4B | ||
| Q2 24 | $2.3B | $3.3B | ||
| Q1 24 | $2.3B | $3.2B |
负债/权益比HOVOPCH
| Q4 25 | 1.08× | — | ||
| Q3 25 | 1.03× | 0.86× | ||
| Q2 25 | 1.05× | 0.82× | ||
| Q1 25 | 1.10× | 0.82× | ||
| Q4 24 | 1.12× | 0.79× | ||
| Q3 24 | 1.28× | 0.78× | ||
| Q2 24 | 1.44× | 0.79× | ||
| Q1 24 | 1.54× | 0.74× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $169.1M | $139.4M |
| 自由现金流经营现金流 - 资本支出 | $164.0M | $130.2M |
| 自由现金流率自由现金流/营收 | 20.0% | 9.1% |
| 资本支出强度资本支出/营收 | 0.6% | 0.6% |
| 现金转化率经营现金流/净利润 | — | 2.69× |
| 过去12个月自由现金流最近4个季度 | $166.2M | $220.7M |
8季度趋势，按日历期对齐
经营现金流HOVOPCH
| Q4 25 | $169.1M | — | ||
| Q3 25 | $52.8M | $139.4M | ||
| Q2 25 | $22.3M | $90.3M | ||
| Q1 25 | $-55.9M | $-7.2M | ||
| Q4 24 | $115.8M | $36.1M | ||
| Q3 24 | $-92.3M | $160.4M | ||
| Q2 24 | $89.1M | $195.7M | ||
| Q1 24 | $-89.0M | $-68.8M |
自由现金流HOVOPCH
| Q4 25 | $164.0M | — | ||
| Q3 25 | $45.8M | $130.2M | ||
| Q2 25 | $16.0M | $81.2M | ||
| Q1 25 | $-59.6M | $-16.6M | ||
| Q4 24 | $111.4M | $25.8M | ||
| Q3 24 | $-95.8M | $150.7M | ||
| Q2 24 | $84.7M | $185.9M | ||
| Q1 24 | $-94.4M | $-74.6M |
自由现金流率HOVOPCH
| Q4 25 | 20.0% | — | ||
| Q3 25 | 5.7% | 9.1% | ||
| Q2 25 | 2.3% | 5.7% | ||
| Q1 25 | -8.8% | -1.2% | ||
| Q4 24 | 11.4% | 2.0% | ||
| Q3 24 | -13.3% | 11.8% | ||
| Q2 24 | 12.0% | 15.1% | ||
| Q1 24 | -15.9% | -6.5% |
资本支出强度HOVOPCH
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.9% | 0.6% | ||
| Q2 25 | 0.9% | 0.6% | ||
| Q1 25 | 0.5% | 0.7% | ||
| Q4 24 | 0.5% | 0.8% | ||
| Q3 24 | 0.5% | 0.8% | ||
| Q2 24 | 0.6% | 0.8% | ||
| Q1 24 | 0.9% | 0.5% |
现金转化率HOVOPCH
| Q4 25 | — | — | ||
| Q3 25 | 3.18× | 2.69× | ||
| Q2 25 | 1.13× | 1.79× | ||
| Q1 25 | -1.98× | -0.15× | ||
| Q4 24 | 1.23× | 0.60× | ||
| Q3 24 | -1.27× | 2.98× | ||
| Q2 24 | 1.75× | 3.69× | ||
| Q1 24 | -3.72× | -1.54× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HOV
| Home Building | $789.8M | 97% |
| Financial Services | $28.1M | 3% |
| Management Fees | $7.1M | 1% |
OPCH
| Commercial Customer | $1.3B | 87% |
| Government Customer | $172.8M | 12% |
| Patient Customer | $10.1M | 1% |
| Corporate Joint Venture | $1.9M | 0% |
